Vertex Pharmaceuticals (VRTX) Q3 2023 Earnings Call Transcript

Nov 7, 2023 · Vertex Pharmaceuticals (VRTX 0.93%) Q3 2023 Earnings Call Nov 06, 2023, 4:30 p.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared …

93%
OFF

Vertex Pharmaceuticals (VRTX) Q3 2023 Earnings Call Transcript

2 weeks from now

Nov 7, 2023 · Vertex Pharmaceuticals (VRTX 0.93%) Q3 2023 Earnings Call Nov 06, 2023, 4:30 p.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared …

fool.com

39%
OFF

Vertex Pharmaceuticals Incorporated (VRTX) Q3 2023 Earnings Call ...

2 weeks from now

Nov 7, 2023 · Play Call 10-Q EPS of $4.08 beats by $0.11 | Revenue of $2.48B (6.39% Y/Y) misses by $18.25M Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX ) Q3 2023 …

seekingalpha.com

6%
OFF

Vertex Pharmaceuticals Inc (VRTX) Reports 6% Increase In Q3 2023 ...

2 weeks from now

Nov 6, 2023 · Vertex Pharmaceuticals Inc (NASDAQ:VRTX) released its earnings report for the third quarter ended September 30, 2023, on November 6, 2023. The company reported a 6% …

yahoo.com

12%
OFF

Vertex Pharmaceuticals Inc (VRTX) Q3 2024 Earnings Call …

2 weeks from now

Nov 5, 2024 · For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points. Vertex Pharmaceuticals Inc (NASDAQ:VRTX) reported a 12% year …

yahoo.com

14%
OFF

Vertex Pharmaceuticals (VRTX) Q4 2023 Earnings Call Transcript

2 weeks from now

Feb 5, 2024 · VRTX earnings call for the period ending December 31, 2023. Image source: The Motley Fool. Vertex Pharmaceuticals ( VRTX -1.14% ) Q4 2023 Earnings Call Feb 05, 2024 , …

fool.com

14%
OFF

Vertex Pharmaceuticals (VRTX) Earnings: 2Q23 Key Numbers

2 weeks from now

Aug 2, 2023 · Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported product revenue of $2.49 billion for the second quarter of 2023, which was up 14% year-over-year. Net income …

alphastreet.com

7%
OFF

Vertex Pharmaceuticals Earnings Preview: What To Expect

2 weeks from now

2 days ago · With Vertex Pharmaceuticals gearing up to release its fourth ... However, shares rose 5.7% following its strong Q3 earnings release on ... The average analyst price target for …

nasdaq.com

2%
OFF

Vertex (VRTX) Q3 Earnings On The Horizon: Analysts' Insights

2 weeks from now

Oct 30, 2024 · In its upcoming report, Vertex Pharmaceuticals (VRTX) is predicted by Wall Street analysts to post quarterly earnings of $4.13 per share, reflecting an increase of 1.2% …

nasdaq.com

5%
OFF

Vertex Pharmaceuticals Earnings Preview: What To Expect - MSN

2 weeks from now

Ahead of the event, analysts expect Vertex to report a profit of $3.41 per share on a diluted basis, down 4.5% from $3.57 per share in the year-ago quarter. The company beat the consensus ...

msn.com

$0.16
OFF

Vertex (VERX) Earnings Date And Reports 2025 - MarketBeat

2 weeks from now

2 days ago · Vertex announced Q3 2024 earnings on November 6, 2024, reporting an EPS of $0.16, which topped analysts' consensus estimates of $0.14 by $0.02. Quarterly revenue rose …

marketbeat.com

FAQs about Vertex Pharmaceuticals (VRTX) Q3 2023 Earnings Call Transcript Coupon?

Is Vertex Pharmaceuticals Incorporated (VRTX) a good stock to buy?

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q4 2023 Earnings Call Transcript February 5, 2024 Vertex Pharmaceuticals Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter ( see the details here ). Operator: Good day, and welcome to the Vertex Pharmaceuticals Fourth Quarter 2023 Earnings Call. ...

Does Vertex Pharmaceuticals Incorporated beat earnings expectations?

Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $3.97, expectations were $3.92. Operator: Good day and welcome to the Vertex Pharmaceuticals Third Quarter 2023 Conference Call. All participants will be in a listen only mode. ...

How did Vertex Pharmaceuticals perform in fiscal 2024?

Vertex Pharmaceuticals exceeded earnings expectations in the last quarter, driven by strong demand for its cystic fibrosis therapies and operational efficiency. In fiscal 2024, analysts expect the company to report a loss of $1.90, down 113.8% from $13.80 in fiscal 2023. ...

Is Vertex Pharmaceuticals Incorporated a good stock to buy?

Vertex Pharmaceuticals Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter ( see the details here ). Operator: Good day, and welcome to the Vertex Pharmaceuticals Fourth Quarter 2023 Earnings Call. All participants will be in a listen-only mode. ...

Will suzetrigine launch success affect Vertex Pharmaceuticals Inc (VRTX)?

The company faces challenges in ensuring broad access and reimbursement for new therapies like suzetrigine, which may impact launch success. Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is investing heavily in commercial and R&D expenses, which increased by 39% year-over-year, potentially impacting profitability. ...